Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis.
Journal: Allergy and asthma proceedings
Published: March 17, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.
Journal: The World Allergy Organization journal
Published: December 22, 2025
Lanadelumab in Hereditary Angioedema: Extending Dose Intervals from Every 2 Weeks to Every 4 Weeks.
Journal: International archives of allergy and immunology
Published: December 21, 2025
Sebetralstat for breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis in KONFIDENT-S.
Journal: The journal of allergy and clinical immunology. Global
Published: December 01, 2025
Long-term prophylaxis in hereditary angioedema: Real-world treatment patterns and healthcare resource utilization.
Journal: The World Allergy Organization journal
Published: November 21, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-S.
Journal: Clinical and translational allergy
Published: July 31, 2025
Long-term prophylactic treatment preferences and willingness to switch therapy in individuals with hereditary angioedema.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: July 24, 2025
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 16, 2025
Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More Years.
Journal: International archives of allergy and immunology
Published: February 27, 2025
Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study.
Journal: Advances in therapy
Published: February 20, 2025
The utility of shared decision making in the management of hereditary angioedema.
Journal: Allergy and asthma proceedings
Published: November 09, 2024
Interplay between on-demand treatment trials for hereditary angioedema and treatment guidelines.
Journal: The Journal of allergy and clinical immunology
Published: October 31, 2024
Last Updated: 09/26/2026